Medpace Holdings, Inc. to Present at the Jefferies Virtual Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) has announced its participation in the Jefferies Virtual Healthcare Conference on June 2, 2021, at 9:00 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference:
Jefferies Virtual Healthcare Conference
Date: Wednesday, June 2, 2021
Presentation: 9:00 a.m. ET
Speakers: August Troendle, President & Chief Executive Officer, Jesse Geiger, Chief Financial Officer & Chief Operating Officer, Laboratory Operations, and Kevin Brady, Executive Director of Finance
A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.medpace.com and will be available for replay following the event.
About Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,900 people across 40 countries as of March 31, 2021.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210518006056/en/